A combinatory treatment of Hepatitis C drugs with Remdesivir show strong effectiveness against COVID-19
Science News reported that a combination of remdesivir, a drug formulated by SBECD and currently approved in the United States
Tag: hepatitis C
Pharmaceutical formulation of lonafarnib with sulfobutylether beta cyclodextrin
A PCT patent application on lonafarnib / SBECD formulation was published on 20 May 2021 (WO2021095008, CycloLab, Hungary). By using